Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
Pasello G, Fabricio ASC, Del Bianco P, Salizzato V, Favaretto A, Piccin L, Zustovich F, Fabozzi A, De Rossi C, Pigozzo J, De Nuzzo M, Cappelletto E, Bonanno L, Palleschi D, De Salvo GL, Guarneri V, Gion M, Chiarion-Sileni V.
Pasello G, et al. Among authors: fabricio asc.
J Transl Med. 2024 Mar 5;22(1):242. doi: 10.1186/s12967-024-04920-6.
J Transl Med. 2024.
PMID: 38443899
Free PMC article.